In July, the six viral marker assay conversion at CTS Dallas, Phoenix and Tampa laboratories was achieved with minimal disruption and substantial cost saving to our healthcare partners.
Transitioned all 5 CTS labs from an investigational new drug (IND) to a licensed pooled Babesia test...
In 2016, CTS tested more source plasma samples (4.9 million) than blood donor samples (4.5 million).
Continue to meet or exceed healthcare partners’ expectations by providing on-time test results appr...
In August CTS begins source plasma testing as a new line of business to one of the largest plasma fr...
By the end of 2017, CTS has secured three source plasma partners and continues to seek additional pa...
CTS Tampa lab implements Dengue testing on behalf of a healthcare partner in an endemic area.